NOREEN ZAMBRANA

Allopathic & Osteopathic Physicians|Family Medicine PEMBROKE PINES, FL NPI 1679601892

General Payments — all program years on this page

$3,732.32

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 115
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $485.24 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $485.2415

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $286.815
Lilly USA, LLC $89.325
Novo Nordisk AS $47.892
Exact Sciences Corporation $26.851
ABBVIE INC. $20.001
BOSTON SCIENTIFIC CORPORATION $14.371

By program year

Program yearAmountRecords
2018 $499.1815
2019 $831.2527
2020 $520.7610
2021 $693.0323
2022 $175.709
2023 $527.1616
2024 $485.2415

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1092421873 Boston Scientific Corporation $14.37 02/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097247873 Novo Nordisk Inc $24.46 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097354352 Novo Nordisk Inc $23.43 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104757356 AstraZeneca Pharmaceuticals LP $95.33 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105502980 AstraZeneca Pharmaceuticals LP $22.73 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105506576 AstraZeneca Pharmaceuticals LP $20.46 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105612297 AstraZeneca Pharmaceuticals LP $124.99 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105865676 AstraZeneca Pharmaceuticals LP $23.30 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106389884 ABBVIE INC. $20.00 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114958047 Exact Sciences Corporation $26.85 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135179977 Lilly USA, LLC $16.98 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135246844 Lilly USA, LLC $13.93 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135253549 Lilly USA, LLC $27.39 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135295233 Lilly USA, LLC $15.73 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135295621 Lilly USA, LLC $15.29 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.